The combination of radiotherapy and ALK inhibitors is effective in the treatment of intraosseous rhabdomyosarcoma with FUS-TFCP2 fusion transcript.
Anne Cecile BrunacAnne LaprieMarie-Pierre CastexCamille LaurentFrançois Le LoarerMarie KaranianSophie Le GellecDelphine GuillemotGaelle PierronAnne Gomez-BrouchetPublished in: Pediatric blood & cancer (2020)